2018
Guanfacine treatment for prefrontal cognitive dysfunction in older participants: a randomized clinical trial
Barcelos NM, Van Ness PH, Wagner AF, MacAvoy MG, Mecca AP, Anderson GM, Trentalange M, Hawkins KA, Sano M, Arnsten AFT, van Dyck CH. Guanfacine treatment for prefrontal cognitive dysfunction in older participants: a randomized clinical trial. Neurobiology Of Aging 2018, 70: 117-124. PMID: 30007160, PMCID: PMC6503670, DOI: 10.1016/j.neurobiolaging.2018.05.033.Peer-Reviewed Original ResearchConceptsDose of guanfacineQuality of lifeZ-scoreCognitive functionPrefrontal cognitive dysfunctionCommon adverse eventsPrimary outcome measureRandomized clinical trialsGlobal functionOlder participantsHealthy older participantsPrefrontal cognitive functionDry mouthAdverse eventsAgonist guanfacineClinical trialsGuanfacine treatmentCognitive dysfunctionMean changeOutcome measuresPlaceboGuanfacineOlder individualsWeeksDose
2015
RBANS Norms based on the Relationship of Age, Gender, Education, and WRAT-3 Reading to Performance within an Older African American Sample
Andreotti C, Hawkins KA. RBANS Norms based on the Relationship of Age, Gender, Education, and WRAT-3 Reading to Performance within an Older African American Sample. The Clinical Neuropsychologist 2015, 29: 442-465. PMID: 26035646, DOI: 10.1080/13854046.2015.1039589.Peer-Reviewed Original Research
2011
Age and Gender but Not Common Chronic Illnesses Predict Odor Identification in Older African Americans
Hawkins KA, Pearlson GD. Age and Gender but Not Common Chronic Illnesses Predict Odor Identification in Older African Americans. American Journal Of Geriatric Psychiatry 2011, 19: 777-782. PMID: 21873833, DOI: 10.1097/jgp.0b013e3181f7d8e1.Peer-Reviewed Original ResearchConceptsBrief Smell Identification TestOlder African AmericansChronic illnessBSIT scoresHealthy older African AmericansCommon chronic illnessCommon chronic conditionsLoss of smellSmell Identification TestAfrican AmericansSpecific neurodegenerative diseasesThyroid disordersChronic conditionsLimited normative dataClinical utilityOlder subjectsAge 55Odor identificationNeurodegenerative diseasesGeneral communityEarly detectionMinority cohortGlobal cognitionDemographic predictorsIdentification TestMini-Mental State Exam Performance of Older African Americans: Effect of Age, Gender, Education, Hypertension, Diabetes, and the Inclusion of Serial 7s Subtraction Versus “World” Backward on Score
Hawkins KA, Cromer JR, Piotrowski AS, Pearlson GD. Mini-Mental State Exam Performance of Older African Americans: Effect of Age, Gender, Education, Hypertension, Diabetes, and the Inclusion of Serial 7s Subtraction Versus “World” Backward on Score. Archives Of Clinical Neuropsychology 2011, 26: 645-652. PMID: 21813555, DOI: 10.1093/arclin/acr054.Peer-Reviewed Original Research
2009
The effects of apolipoprotein E on non-impaired cognitive functioning: A meta-analysis
Wisdom NM, Callahan JL, Hawkins KA. The effects of apolipoprotein E on non-impaired cognitive functioning: A meta-analysis. Neurobiology Of Aging 2009, 32: 63-74. PMID: 19285755, DOI: 10.1016/j.neurobiolaging.2009.02.003.Peer-Reviewed Original ResearchMeSH KeywordsAge FactorsApolipoproteins ECognitionDatabases, FactualHumansNeuropsychological TestsPublication BiasZygoteConceptsGlobal cognitive abilityEpisodic memoryCognitive abilitiesApoE allele 4Previous meta-analytic findingsMeta-analytic findingsPossible moderating variablesHealthy adultsPerceptual speedExecutive functioningCognitive functioningNeurocognitive functionNeurocognitive examinationModerating variableCurrent studyMemoryFunctioningSmall effectAdultsMeasuresPrevious examinationsAbilityParticipantsCurrent literatureAllele 4